Seeking Alpha: It's Getting Harder To Give Axiall The Benefit Of The Doubt

At some point a company's problems cease to be cyclical and start looking increasingly structural. I'm getting close to that point with Axiall (NYSE:AXLL). Six consecutive earnings misses may say more about the analysts following the stock than the quality of the company, but management's own missteps and changes in the chloralkali space have more concerned about the prospects for this company. I do still believe that the company can leverage positives like an improving U.S. construction market (whenever that arrives...) and increasing shale gas production, but I'm not convinced that the value is so compelling as to be worth the risk anymore.

Continue reading here:
It's Getting Harder To Give Axiall The Benefit Of The Doubt